Artiva Biotherapeutics, Inc. ARTV Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Artiva Biotherapeutics, Inc. (ARTV) reported accretion (amortization) of discounts and premiums, investments of $199K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Artiva Biotherapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 72.5% year-over-year, from $723K to $199K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Reflects the non-cash adjustment to the carrying value of investment securities to account for the amortization of premiums or accretion of discounts over the life of the instrument. This ensures that interest income is recognized effectively over the holding period rather than solely upon maturity or sale.